Skip to main content

Table 4 Operative details: the bypass data were compatible

From: Is there a renoprotective value to leukodepletion during heart valve surgery? A randomized controlled trial (ROLO)

Operation detail

 

Randomized to leukodepletion filter (n = 32)

Randomized to standard

filter (n = 31)

Overall

(n = 63)

n

%

n

%

n

%

Type of surgery

Valve

15/31a

48%

18/31

58%

33/62

53%

CABG and valve

11/31a

35%

10/31

32%

21/62

34%

Valve and other

5/31a

16%

3/31

10%

8/62

13%

Valve replacement

 

26/31a

84%

25/31

81%

51/62

82%

Valve repair

 

8/31a

26%

7/31

23%

15/62

24%

Valve Replacement Details

Aortic

23/26

88%

24/25

96%

47/51

92%

Mitral

3/26

12%

1/25

4%

4/51

8%

Valve Repair Details

Mitral

4/8

50%

5/7

71%

9/15

60%

Tricuspid

3/8

38%

2/7

29%

5/15

33%

Pulmonary

1/8

13%

0/7

0%

1/15

7%

BYPASS DATA

Total CPB duration (minutes)

Median (IQR)

119.0

(97.0, 151.0)

124.0

(107.0, 141.0)

123.5

(99.0, 146.0)

  1. Details on missing data (Leukodepletion, Standard): (1, 0)
  2. IQR interquartile
  3. a1 patient in the leukodepletion filter group was missing CPB specific data, as this patient was an open and shut case